FDA shares research to improve dose selection in pediatric drug development
Regulatory NewsMary Ellen Schneider
Clinical TrialsHealth Authority meeting and communication strategyNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsMary Ellen SchneiderClinical TrialsHealth Authority meeting and communication strategyNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy